Why the ResMed (ASX:RMD) share price is down 11% today
Luke Laretive
August 4, 2023
ResMed CDI (ASX: RMD) shares are trading down about -11%
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
ResMed CDI (ASX: RMD) shares are trading down about -11%
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today
Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd
LIVE ASX reporting season coverage is on The Australian Investors
On Wednesday, the Australian share market, or S&P/ASX 200 (INDEXASX:
Here are my three key investor takeaways from a shortened
The S&P/ASX 200 (ASX:XJO) finished flat on Wednesday as Ramsay
It was another weak day for the S&P/ASX 200 (ASX:
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
